Document is current
Any future updates will be listed below
-
Authors
Rathmann, Wolfgang https://orcid.org/0000-0001-7804-1740
Kostev, Karel
- License Information
-
More Information
Article History
Received: 23 February 2024
Accepted: 3 March 2024
First Online: 2 April 2024
Declarations
:
: W.R. reports the receipt of consulting fees for attending educational sessions by Novo Nordisk outside of the topic of the current work. K.K. reports no conflict of interest.
: The Disease Analyzer database, used for analysis, contains anonymized electronic patient records. Patient data was analyzed in aggregated form without individual data being available. Patient consent and ethical approval was waived due to national and European legislation.
